small molecule

VANCOMYCIN HYDROCHLORIDE

VANCOMYCIN HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyAmneal Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameVANCOMYCIN HYDROCHLORIDE
Active ingredientVANCOMYCIN HYDROCHLORIDE
StrengthEQ 250MG BASE/5ML
Dosage formFOR SOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalJune 2023
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.